TP53 and neoplasm: The exome sequencing of both tumor and normal cells of the patient presented a low rate of mutations; when validated by RNASeq, expressed mutations discovered in previous studies were conformed, which are DICER1 and NF1. Amplification of MYC and deletion of TP53 were found in CNV results, which are commonly discovered in similar neoplasms (20).